|Day Low/High||5.13 / 5.30|
|52 Wk Low/High||1.40 / 7.12|
Investors in Conatus Pharmaceuticals Inc saw new options become available this week, for the June 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CNAT options chain for the new June 16th contracts and identified one put and one call contract of particular interest.
Biotech investors should keep a close eye on the progress in this huge potential market.
I've got my eye on steel and biotechnology names to put cash to work.
Rev Shark steps in for Jim Cramer this week.
Thin trading is impeding momentum, but here are 4 stocks on my radar.
Will pension funds sell stocks after their run higher in order to maintain the same allocation levels to bonds and equities?
Markets look set to continue their election rally as violence casts a pall over Europe.
Conatus Pharmaceuticals (CNAT) stock was boosted on Tuesday after Allergan (AGN) agreed to buy Tobira Therapeutics (TBRA) at a 500% premium.